Optogenetics pioneer Karl Deisseroth, MD, PhD, will speak at Vanderbilt’s upcoming Discovery Lecture on Thursday, March 17.
Histamine — commonly associated with allergies — also has a signaling role in the brain’s reward center and may offer a novel target for treating addiction.
Ishmail Abdus-Saboor, postdoctoral fellow in the Department of Neuroscience at the University of Pennsylvania, will deliver the School of Medicine’s next Discovery Sciences Emerging Scholars Lecture with the topic is “Genetic Interrogation of Neural Circuit Mechanisms for Pain.”
Vanderbilt researchers have identified cocaine-induced modifications at specific neuronal connections, which could aid the development of new therapies for substance abuse disorders.
A team of Vanderbilt scientists have genetically modified luciferase, the enzyme that produces bioluminescence, so that it acts as an optical sensor that records activity in brain cells.
A new light-based technology is allowing scientists to peer deep into the brain and alter animal behavior with the “flip of a switch.”
Accessibility Tools